DOJ Actions Suggest Expansion Of Healthcare Enforcement
By James Koukios and Liz Aloi · March 27, 2026, 5:46 PM EDT
Recent actions by the U.S. Department of Justice and U.S. Food and Drug Administration suggest a notable shift in federal healthcare enforcement away from traditional program-based fraud and toward cases centered...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login